iohexol has been researched along with carboplatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Holländer, C | 1 |
| Bailey, DB; Dykes, NL; Prey, JD; Rassnick, KM | 1 |
| Beumer, JH; Christner, S; Chu, E; Guo, J; Holleran, JL; Ivy, SP; Joshi, A; Kiesel, B; Miller, BM; Parise, RA; Taylor, S; Venkataramanan, R | 1 |
3 other study(ies) available for iohexol and carboplatin
| Article | Year |
|---|---|
[Delay in implementation of international guidelines for computed tomographies with iodinated contrast media].
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Contrast Media; Creatinine; Guideline Adherence; Humans; Iohexol; Iopamidol; Kidney Diseases; Lung Neoplasms; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2009 |
Evaluation of serum iohexol clearance for use in predicting carboplatin clearance in cats.
Topics: Animals; Area Under Curve; Body Surface Area; Body Weight; Carboplatin; Carcinoma; Cat Diseases; Cats; Chromatography, High Pressure Liquid; Glomerular Filtration Rate; Iohexol; Metabolic Clearance Rate; Sarcoma; Technetium Tc 99m Pentetate | 2009 |
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker.
Topics: Administration, Intravenous; Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow; Carboplatin; Contrast Media; Creatinine; Cytochrome P-450 Enzyme System; Deoxycytidine; Drug Dosage Calculations; Drug Interactions; Female; Gemcitabine; Glomerular Filtration Rate; Glucuronosyltransferase; Humans; Iohexol; Kidney; Metabolic Clearance Rate; Mice; Microsomes, Liver; Models, Animal; Paclitaxel; Specific Pathogen-Free Organisms; Tandem Mass Spectrometry; Tissue Distribution | 2020 |